Intercept Pharmaceuticals, Inc.

CIK 1270073 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Intercept Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Nov 20, 202315-12G0001104659-23-119815
Nov 14, 2023EFFECT9999999995-23-003317
Nov 14, 2023EFFECT9999999995-23-003320
Nov 14, 2023EFFECT9999999995-23-003316
Nov 13, 202340001104659-23-117110
Nov 13, 202340001104659-23-117099
Nov 13, 202340001104659-23-117102
Nov 13, 202340001104659-23-117112
Nov 13, 202340001104659-23-117104
Nov 13, 202340001104659-23-117096
Nov 13, 202340001104659-23-117097
Nov 13, 202340001104659-23-117100
Nov 13, 202340001104659-23-117093
Nov 13, 202340001104659-23-117115
Nov 13, 202340001104659-23-117105
Nov 13, 202340001104659-23-117094
Nov 13, 202340001104659-23-117106
Nov 13, 202340001104659-23-117117
Nov 13, 202340001104659-23-117109
Nov 13, 202340001104659-23-117119
Nov 13, 202340001104659-23-117113
Nov 8, 2023S-8 POS0001104659-23-115746
Nov 8, 2023POS AM0001104659-23-115755
Nov 8, 2023S-8 POS0001104659-23-115736
Nov 8, 2023S-8 POS0001104659-23-115744